Skip to main content
Equibles

Christopher D. Galloway

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Christopher D. Galloway

CervoMed Inc. reported in an 8-K filed February 16, 2023 that Christopher D. Galloway was terminated as Chief Medical Officer, effective March 1, 2023.

“As part of the reduction in force, the Company determined that Dr. Christopher D. Galloway, M.D., the Company's Chief Medical Officer, will depart Diffusion effective March 1, 2023.”
CervoMed Inc. Form 8-K, filed February 16, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.